HUKX:SW:SW-HSBC FTSE 100 UCITS ETF USD (USD)

ETF | Others |

Last Closing

USD 95.19

Change

0.00 (0.00)%

Market Cap

USD 0.49B

Volume

93.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

-0.05 (-0.42%)

USD 1,244,681.59B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

-0.15 (-0.76%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

-0.44 (-1.65%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+56.00 (+1.08%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+35.40 (+2.20%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+5.50 (+0.25%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

-0.76 (-1.03%)

USD 131,872.43B
SPMCHA:SW UBS ETF (CH) – SPI® Mid (CH..

-0.52 (-0.48%)

USD 130,595.12B

ETFs Containing HUKX:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 1.49% 15% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.49% 14% F 21% F
Trailing 5 Years  
Capital Gain 1.36% 36% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.36% 33% F 46% F
Average Annual (5 Year Horizon)  
Capital Gain 4.98% 54% F 56% F
Dividend Return 4.98% 54% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.92% 23% F 49% F
Risk Adjusted Return 35.81% 28% F 34% F
Market Capitalization 0.49B 58% F 54% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.